A March 2025 study shows mild acidosis increases frailty risk by 40% in seniors with normal kidney function, pointing to dietary interventions and alkali supplementation. A March 2025 study found low ...
New single-cell studies reveal distinct immune aging trajectories in women and men, with implications for personalized vaccines, autoimmune monitoring, and cancer screening. The immune system ages dif...
A 2023 study in the Journal of Cachexia, Sarcopenia and Muscle finds rapamycin reduces muscle protein synthesis after exercise in older adults, highlighting trade-offs in longevity strategies. Recent ...
Phase 1 data for BGE-102 demonstrates significant reductions in hsCRP and inflammatory biomarkers, positioning it as a potential best-in-class therapy for cardiovascular risk and age-related inflammat...
Mitrix Bio leverages Right to Try laws and medical tourism for early human data on mitochondrial transplants, reflecting a biotech shift to reduce costs and speed innovation amid ethical debates. Mitr...
Recent studies uncover ATF5’s role in aging muscle, offering insights into sarcopenia but cautioning against direct targeting, with research pivoting to alternative strategies for improved muscl...
A recent study reveals that combining NMN and apigenin restores muscle and bone in aged mice, highlighting potential anti-aging therapies through NAD+ modulation. New research on NMN and apigenin offe...
ER-100 targets glaucoma and NAION through epigenetic reprogramming, with Phase II trials advancing, highlighting potential economic and healthcare disruptions in anti-aging therapies. Life Biosciences...
Recent studies reveal that aligning meal times with circadian rhythms can slow biological aging and improve metabolic health, offering non-pharmaceutical strategies for longevity. New research highlig...
Life Biosciences launches a Phase I trial for cellular reprogramming to treat age-related macular degeneration, challenging aging norms with FDA’s Plausible Mechanism Pathway, amid rising invest...
